Cargando…
Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284968/ https://www.ncbi.nlm.nih.gov/pubmed/37103743 http://dx.doi.org/10.1007/s12282-023-01454-5 |
| _version_ | 1785061508704632832 |
|---|---|
| author | Tomioka, Nobumoto Hatanaka, Kanako C. Okuyama, Dai Watanabe, Ken-ichi Yamamoto, Mitsugu Maeda, Hideki Tachikawa, Hanae Kuwahara, Sayuri Shimizu, Ai Suzuki, Hiroaki Hatanaka, Yutaka Takahashi, Masato |
| author_facet | Tomioka, Nobumoto Hatanaka, Kanako C. Okuyama, Dai Watanabe, Ken-ichi Yamamoto, Mitsugu Maeda, Hideki Tachikawa, Hanae Kuwahara, Sayuri Shimizu, Ai Suzuki, Hiroaki Hatanaka, Yutaka Takahashi, Masato |
| author_sort | Tomioka, Nobumoto |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10284968 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Nature Singapore |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102849682023-06-23 Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region Tomioka, Nobumoto Hatanaka, Kanako C. Okuyama, Dai Watanabe, Ken-ichi Yamamoto, Mitsugu Maeda, Hideki Tachikawa, Hanae Kuwahara, Sayuri Shimizu, Ai Suzuki, Hiroaki Hatanaka, Yutaka Takahashi, Masato Breast Cancer Correction Springer Nature Singapore 2023-04-27 2023 /pmc/articles/PMC10284968/ /pubmed/37103743 http://dx.doi.org/10.1007/s12282-023-01454-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Tomioka, Nobumoto Hatanaka, Kanako C. Okuyama, Dai Watanabe, Ken-ichi Yamamoto, Mitsugu Maeda, Hideki Tachikawa, Hanae Kuwahara, Sayuri Shimizu, Ai Suzuki, Hiroaki Hatanaka, Yutaka Takahashi, Masato Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region |
| title | Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region |
| title_full | Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region |
| title_fullStr | Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region |
| title_full_unstemmed | Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region |
| title_short | Correction: Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region |
| title_sort | correction: programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284968/ https://www.ncbi.nlm.nih.gov/pubmed/37103743 http://dx.doi.org/10.1007/s12282-023-01454-5 |
| work_keys_str_mv | AT tomiokanobumoto correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT hatanakakanakoc correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT okuyamadai correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT watanabekenichi correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT yamamotomitsugu correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT maedahideki correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT tachikawahanae correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT kuwaharasayuri correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT shimizuai correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT suzukihiroaki correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT hatanakayutaka correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion AT takahashimasato correctionprogrammeddeathligand1positiveimmunecellsinprimarytumorormetastaticaxillarylymphnodescanpredictprognosisoftriplenegativebreastcancerevenwhenpresentat1inthetumorregion |